Bristol-Myers Squibb Company (TSX:BMY)
22.75
-0.31 (-1.34%)
Nov 10, 2026, 9:50 AM EST
Bristol-Myers Squibb Company Employees
Bristol-Myers Squibb Company had 32,500 employees as of December 31, 2025. The number of employees decreased by 1,600 or 4.69% compared to the previous year.
Employees
32,500
Change (1Y)
-1,600
Growth (1Y)
-4.69%
Revenue / Employee
2.19M CAD
Profits / Employee
403.75K CAD
Market Cap
177.03B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 32,500 | -1,600 | -4.69% |
| Dec 31, 2024 | 34,100 | 0 | - |
| Dec 31, 2023 | 34,100 | -200 | -0.58% |
| Dec 31, 2022 | 34,300 | 2,100 | 6.52% |
| Dec 31, 2021 | 32,200 | 1,950 | 6.45% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Extendicare | 23,500 |
| Sienna Senior Living | 15,000 |
| Apotex Health | 6,000 |
| Curaleaf Holdings | 5,554 |
| Green Thumb Industries | 4,900 |
| Verano Holdings | 3,800 |
| WELL Health Technologies | 1,507 |
| Knight Therapeutics | 830 |
Bristol-Myers Squibb Company News
- 4 days ago - Bristol Myers presents 56-week data from Phase 3 SCOUT-HCM clinical trial - TheFly
- 4 days ago - Bristol Myers Squibb Presents 56-Week Phase 3 Data in Pediatric Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (oHCM) for Camzyos (mavacamten) at the Hypertrophic Cardiomyopathy Medical Society (HCMS) Scientific Sessions - Business Wire
- 4 days ago - Bristol Myers Squibb put volume heavy and directionally bearish - TheFly
- 5 days ago - Bristol Myers Squibb put volume heavy and directionally bearish - TheFly
- 11 days ago - Bristol Myers price target lowered to $40 from $41 at Morgan Stanley - TheFly
- 11 days ago - Bristol Myers price target lowered to $60 from $65 at Wells Fargo - TheFly
- 11 days ago - How Bristol Myers's CEO Challenged the Company's Managers - WSJ
- 12 days ago - Bristol-Myers Squibb Company Earnings Call Transcript: Q3 2026 - Transcripts